138 related articles for article (PubMed ID: 11739983)
1. Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST).
Wilterdink JL; Bendixen B; Adams HP; Woolson RF; Clarke WR; Hansen MD
Stroke; 2001 Dec; 32(12):2836-40. PubMed ID: 11739983
[TBL] [Abstract][Full Text] [Related]
2. The NIHSS supplementary motor scale: a valid tool for multidisciplinary recovery trials.
Leira EC; Coffey CS; Jorge RE; Morton SM; Froehler MT; Davis PH; Adams HP
Cerebrovasc Dis; 2013; 36(1):69-73. PubMed ID: 23921195
[TBL] [Abstract][Full Text] [Related]
3. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).
Adams HP; Davis PH; Leira EC; Chang KC; Bendixen BH; Clarke WR; Woolson RF; Hansen MD
Neurology; 1999 Jul; 53(1):126-31. PubMed ID: 10408548
[TBL] [Abstract][Full Text] [Related]
4. Differences between anterior and posterior circulation stroke in TOAST.
Libman RB; Kwiatkowski TG; Hansen MD; Clarke WR; Woolson RF; Adams HP
Cerebrovasc Dis; 2001; 11(4):311-6. PubMed ID: 11385210
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
[TBL] [Abstract][Full Text] [Related]
6. Ischemic stroke outcome: racial differences in the trial of danaparoid in acute stroke (TOAST).
Hassaballa H; Gorelick PB; West CP; Hansen MD; Adams HP
Neurology; 2001 Aug; 57(4):691-7. PubMed ID: 11524481
[TBL] [Abstract][Full Text] [Related]
7. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.
Goldstein LB; Jones MR; Matchar DB; Edwards LJ; Hoff J; Chilukuri V; Armstrong SB; Horner RD
Stroke; 2001 May; 32(5):1091-8. PubMed ID: 11340215
[TBL] [Abstract][Full Text] [Related]
8. Classification of subtypes of ischemic stroke: history of the trial of org 10172 in acute stroke treatment classification.
Adams HP; Biller J
Stroke; 2015 May; 46(5):e114-7. PubMed ID: 25813192
[No Abstract] [Full Text] [Related]
9. Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).
Adams HP; Bendixen BH; Leira E; Chang KC; Davis PH; Woolson RF; Clarke WR; Hansen MD
Neurology; 1999 Jul; 53(1):122-5. PubMed ID: 10408547
[TBL] [Abstract][Full Text] [Related]
10. Using change in the National Institutes of Health Stroke Scale to measure treatment effect in acute stroke trials.
Bruno A; Saha C; Williams LS
Stroke; 2006 Mar; 37(3):920-1. PubMed ID: 16439701
[TBL] [Abstract][Full Text] [Related]
11. The Interplay between Stroke Severity, Antiplatelet Use, and Aspirin Resistance in Ischemic Stroke.
Agayeva N; Topcuoglu MA; Arsava EM
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):397-403. PubMed ID: 26576697
[TBL] [Abstract][Full Text] [Related]
12. Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).
Adams HP; Woolson RF; Clarke WR; Davis PH; Bendixen BH; Love BB; Wasek PA; Grimsman KJ
Control Clin Trials; 1997 Aug; 18(4):358-77. PubMed ID: 9257073
[TBL] [Abstract][Full Text] [Related]
13. Immediate use of anticoagulants may not improve stroke outcomes.
Am J Health Syst Pharm; 1998 Jun; 55(12):1240. PubMed ID: 9640462
[No Abstract] [Full Text] [Related]
14. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome.
Park JM; Kang K; Cho YJ; Hong KS; Lee KB; Park TH; Lee SJ; Ko Y; Han MK; Lee J; Cha JK; Kim DH; Kim DE; Kim JT; Choi JC; Yu KH; Lee BC; Lee JS; Lee J; Gorelick PB; Bae HJ;
Ann Neurol; 2016 Apr; 79(4):560-8. PubMed ID: 26754410
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.
Tardy-Poncet B; Tardy B; Reynaud J; Mahul P; Mismetti P; Mazet E; Guyotat D
Chest; 1999 Jun; 115(6):1616-20. PubMed ID: 10378558
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic impact of early transcranial Doppler ultrasonography on the TOAST classification subtype in acute cerebral ischemia.
Wijman CA; McBee NA; Keyl PM; Varelas PN; Williams MA; Ulatowski JA; Hanley DF; Wityk RJ; Razumovsky AY
Cerebrovasc Dis; 2001; 11(4):317-23. PubMed ID: 11385211
[TBL] [Abstract][Full Text] [Related]
18. Prestroke Aspirin Use is Associated with Clinical Outcomes in Ischemic Stroke Patients with Atherothrombosis, Small Artery Disease, and Cardioembolic Stroke.
Lin J; Han Z; Yi X; Luo H; Zhou Q; Zhou J
J Atheroscler Thromb; 2019 Jun; 26(6):528-537. PubMed ID: 30429408
[TBL] [Abstract][Full Text] [Related]
19. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
[TBL] [Abstract][Full Text] [Related]
20. Previous use of aspirin and baseline stroke severity: an analysis of 17,850 patients in the International Stroke Trial.
Ricci S; Lewis S; Sandercock P;
Stroke; 2006 Jul; 37(7):1737-40. PubMed ID: 16741185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
